অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phenoxymethylpenicillin, quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; titanium dioxide; sunset yellow fcf; brilliant blue fcf; magnesium stearate; gelatin; indigo carmine; allura red ac; quinoline yellow aluminium lake; iron oxide black; sd alcohol 3-a - penicilin v potassium is indicated in the treatment of mild to moderately severe infections due to penicillin v sensitive micro-organisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteraemia, pericarditis, meningitis and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phenoxymethylpenicillin, quantity: 250 mg - capsule, hard - excipient ingredients: brilliant blue fcf; magnesium stearate; titanium dioxide; erythrosine; sunset yellow fcf; carbon black; gelatin; indigo carmine; allura red ac; quinoline yellow aluminium lake; iron oxide black; sd alcohol 3-a - treatment of mild to moderately severe infections due to penicillin v sensitive micro-organisms. therapy should be guided by bacteriological studies ( including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteraemia, pericarditis, meningitis and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections( without bacteraemia). mild to moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a,c,g,h,l and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections. mild to moderately severe infections of the respiratory tract. staphylococcal infections-penicillin v sensitive. mild infections of the skin and soft tissues. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin v, emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections. fusospirochetosis (vincent's gingivitis and pharyngitis)-mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin. note: reports indicate an increasing number of strains of staphylococci resistant to penicillin v, emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections. fusospirochetosis( vincent's gingivitis and pharyngitis)-mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin. note; necessary dental care should be accomplished in infections involving the gum tissue. medical conditions in which oral penicillin therapy is indicated as prophylaxis: for the prevention of recurrence following rheumatic fever and/or chorea-prophylaxis with oral penicillin on a continuing basis has proven bacterial endocarditis in patients with congenital and/or rheumatic heart lesions who are to undergo dental procedures or minor upper respiratory tract surgery or instrumentation. prophylaxis should be instituted on the day of the procedure and for 2 or more days following. patients who have a past history of rheumatic fever and are receiving continuous prophylaxis may harbour increased numbers of penicillin-resistant organisms; use of another prophylactic anti-infective agent should be considered. if penicillin is to be used in these patients at surgery, penicillin may be re-instituted as a prophylactic measure against the hazards of surgically induced bacteraemia. note: oral penicillin should not be used as a adjunctive prophylaxis for genito-urinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy and complications of childbirth.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 100 mg - tablet, modified release - excipient ingredients: ethylcellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - relief of painful muscle spasm associated with fibrositis, whiplash injuries, torticollis, prolapsed intervertebral disc, strains, sprains and similar conditions. has also been shown to be of value in tension headache and persistent hiccup.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - clindamycin hydrochloride, quantity: 10 mg/ml - solution - excipient ingredients: dioctyl malate; purified water; ethanol - clindtech solution is indicated for the topical treatment of acne vulgaris, particularly forms in which comedones, papules and pastules predominate.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - prednisone, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; propyl hydroxybenzoate; wheat starch; maize starch; magnesium stearate; gelatin - indications as at 26 march 1997 : wherever corticosteroid therapy is indicated.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - nitrazepam, quantity: 5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - insomnia, organic and inorganic in origin.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - prednisone, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; gelatin; propyl hydroxybenzoate; maize starch; wheat starch - indications as at 26 march 1997 : wherever corticosteroid therapy is indicated.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - prednisolone, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; wheat starch; maize starch; propyl hydroxybenzoate; lactose monohydrate; gelatin - indications as at 26 march 1997 : wherever corticosteroid therapy is indicated.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - prednisolone, quantity: 25 mg - tablet, uncoated - excipient ingredients: wheat starch; magnesium stearate; gelatin; lactose monohydrate; maize starch; propyl hydroxybenzoate - indications as at 26 march 1997 : wherever corticosteroid therapy is indicated.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - theophylline, quantity: 300 mg - tablet, modified release - excipient ingredients: guar gum; magnesium stearate; purified water - for the relief and prophylaxis of reversible bronchospasm associated with bronchial asthma, bronchitis, emphysema and related conditions.